Founded by Vanessa Carter, a patient advocate who survived a highly-resistant MRSA infection, The AMR Narrative was set up to promote and develop advocacy capacity among the public to improve participation and mobilise action against Antimicrobial Resistance (AMR). As patients and consumers, pet owners, parents or carers we play a pivotal role in advocating for the appropriate use of antimicrobial medicines. By protecting antimicrobial medicines in humans, animals, the environment and food sectors we are ensuring a more sustainable future for everyone especially those who are most vulnerable to untreatable infections.
Developing public and patient capacity around AMR to encourage participation and advocacy through ongoing programmes, mentorship, tools and resources
Promoting public understanding and education for Antimicrobial Resistance through access to information and awareness raising
Building community and providing a platform for patients and the public to participate in events related to AMR, discover research projects and networking opportunities
Microbes are part of nature and live all around us. Some of them even live harmoniously inside our bodies, but every now and again a bad one can cause an infection.
Some infections are resistant to the antimicrobial medicines designed to treat them. Microbes, also known as germs, include bacteria, fungi, viruses and parasites.
treat bacterial infections
treat fungal infections
treat viral infections
treat parasitic infections
On the 5th and 6th of September 2024, Dr Francesca Chiara, Chair of the Board of The AMR Narrative, moderated a One Health session at the World AMR Congress in Philadelphia. The session focused on critical topics, including infodemic management around antimicrobial resistance (AMR), wastewater surveillance, antibiotic use in livestock, and alternative treatments. Discussions also covered
Summer Training Course for Young Patient Advocates (STYPA) The AMR Narrative’s Founder and Executive Director, Vanessa Carter, delivered two advocacy training sessions at the European Patients’ Forum (EPF) Summer Training Course for Young Patient Advocates (STYPA) from the 4th to the 7th of July 2024 in Brussels. STYPA is a dedicated annual event for young
On the 31st of May 2024, The AMR Narrative’s Founder and Executive Director, Vanessa Carter, shared her patient journey at the Seventy-seventh World Health Assembly (WHA) held at the UN Palais des Nations in Geneva during a strategic roundtable meeting titled, “Charting a new path forward for global action against antimicrobial resistance”. Vanessa also presented
My Story: Bhakti Chavan My name is Bhakti Chavan and I am an AMR patient survivor from India. As I neared the completion of my master’s degree in biotechnology at the age of 23 in 2017, I encountered a troubling development: gastrointestinal issues. Concerned by this, my father accompanied me to a gastroenterologist, who diagnosed
https://www.youtube.com/watch?v=79QTsFAs0qo My Story: Leticia Batista My name is Leticia Batista. I’m 28 years old and was born in Franca, a city in the state of São Paulo, Brazil. I graduated as a Physical Therapist in 2016 and moved to São Paulo in 2017 to work in a public hospital (Unified Health System – SUS). In
My Story: Olayinka Fakorede My name is Olayinka Fakorede. As a Nigerian-trained medical doctor and someone who has experienced the challenges of malaria firsthand, I can personally relate to the looming threat of malaria resistance in Nigeria and other countries where malaria is endemic. Malaria is an infectious disease transmitted by mosquitoes which are parasites.
Advocacy plays a crucial role towards increasing awareness about the escalating threat of Antimicrobial Resistance (AMR) and the pressing need to take measures to prevent it. Advocacy also serves to educate policymakers, healthcare professionals, and the general public about the significance of using antibiotics and other antimicrobial medicines responsibly. Raising our voices and creating awareness may also help to promote changes in prescribing practices, improved infection prevention and control measures, and increased funding for research and development. Furthermore, advocacy can encourage discussions around reducing the misuse of antimicrobials in food, animals, and the environment which is a significant contributor to the problem of AMR.
Organisations we have partnered or shared our experience with:
This work has been made possible through generous contributions from our supporters:
Sign up to receive the latest news including upcoming events, programmes, AMR educational and advocacy resources and fundraising opportunities.
PRIVACY POLICY | TERMS AND CONDITIONS | SAFEGUARDING POLICY
Sign up to receive the latest news including upcoming events, programmes, AMR educational and advocacy resources and fundraising opportunities.
